I

Inovio Pharmaceuticals
D

INO

1.83000
USD
-0.01
(-0.54%)
Market Closed
Volume
53,883
EPS
-4
Div Yield
-
P/E
-0
Market Cap
66,062,984
OverviewSignalsIdeasNews
Related Instruments
    A
    AMRN
    0.01290
    (2.77%)
    0.47870 USD
    A
    APTX
    0
    (0%)
    0.000000 USD
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    A
    AXSM
    1.160
    (1.29%)
    90.840 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    E
    EDIT
    -0.01000
    (-0.75%)
    1.32000 USD
    I
    INO
    -0.01000
    (-0.54%)
    1.83000 USD
    S
    SRPT
    -0.470
    (-0.39%)
    118.970 USD
    V
    VCEL
    1.530
    (2.78%)
    56.480 USD
    V
    VKTX
    0.780
    (1.88%)
    42.270 USD
    More
News

Title: Inovio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.